Free Trial

Fort Washington Investment Advisors Inc. OH Has $15.80 Million Stock Holdings in Doximity, Inc. $DOCS

Doximity logo with Medical background

Key Points

  • Fort Washington Investment Advisors Inc. OH increased its stake in Doximity, Inc. by 20.8%, owning approximately $15.80 million in stock after acquiring additional shares.
  • Insider trading activity included a significant sale by Director Timothy S. Cabral, who sold 20,000 shares for approximately $1.5 million, representing an 86.13% decrease in his holdings.
  • Doximity reported an earnings per share (EPS) of $0.36 for the last quarter, surpassing analysts' expectations, and has set a FY 2026 EPS guidance.
  • MarketBeat previews the top five stocks to own by October 1st.

Fort Washington Investment Advisors Inc. OH boosted its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 20.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 257,641 shares of the company's stock after purchasing an additional 44,311 shares during the period. Fort Washington Investment Advisors Inc. OH owned 0.14% of Doximity worth $15,804,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of DOCS. GAMMA Investing LLC lifted its holdings in shares of Doximity by 5.9% during the 2nd quarter. GAMMA Investing LLC now owns 2,981 shares of the company's stock valued at $183,000 after buying an additional 165 shares during the last quarter. Amalgamated Bank raised its position in Doximity by 0.3% during the first quarter. Amalgamated Bank now owns 60,928 shares of the company's stock valued at $3,536,000 after acquiring an additional 186 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock valued at $2,262,000 after acquiring an additional 210 shares during the last quarter. Greenleaf Trust grew its position in Doximity by 5.4% in the first quarter. Greenleaf Trust now owns 4,492 shares of the company's stock worth $261,000 after acquiring an additional 230 shares in the last quarter. Finally, Spire Wealth Management increased its stake in shares of Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after purchasing an additional 260 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the sale, the director directly owned 16,618 shares in the company, valued at $948,721.62. This trade represents a 10.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the transaction, the director owned 3,221 shares in the company, valued at approximately $241,575. The trade was a 86.13% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 37,000 shares of company stock valued at $2,581,880. 31.30% of the stock is owned by company insiders.

Doximity Stock Performance

Doximity stock opened at $74.46 on Monday. Doximity, Inc. has a 52 week low of $40.87 and a 52 week high of $85.21. The firm has a market capitalization of $13.95 billion, a PE ratio of 74.46, a PEG ratio of 4.10 and a beta of 1.37. The business's 50-day simple moving average is $66.01 and its 200-day simple moving average is $60.33.

Doximity (NASDAQ:DOCS - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity's revenue was up 15.2% on a year-over-year basis. During the same period last year, the company posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on DOCS. Evercore ISI raised shares of Doximity from an "in-line" rating to an "outperform" rating and lifted their price objective for the company from $50.00 to $70.00 in a research note on Wednesday, July 9th. BTIG Research raised Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target for the company in a research report on Monday, June 2nd. Wells Fargo & Company upped their price target on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research note on Monday, August 4th. Needham & Company LLC raised their price objective on Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Finally, Robert W. Baird boosted their target price on Doximity from $75.00 to $80.00 and gave the stock an "outperform" rating in a report on Thursday, September 11th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $67.42.

Check Out Our Latest Stock Report on DOCS

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Recommended Stories

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.